Pharmanetics, Inc. Form 8-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of
earliest event reported): November 18, 2002
PHARMANETICS, INC.
(Exact name of registrant as specified in its charter)
North Carolina
(State or other jurisdiction of
incorporation)
| 0-25133 |
|
56-2098302 |
| (Commission file Number) |
|
(IRS Employer ID Number) |
9401 Globe Center Drive, Morrisville, North Carolina 27560
(Address of principal executive offices) (Zip Code)
919-582-2600
Registrant’s telephone number, including area code
NA
(Former name or former address, if changed
since last report)
Item 5. Other Events.
On November 18, 2002, the Registrant issued the press release filed herewith as Exhibit
99.1.
Item 7. Exhibits
(c) Exhibits
Exhibit No.
| |
99.1 |
|
Press release issued on November 18, 2002. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
| |
|
|
|
PHARMANETICS, INC. |
| |
| Date: November 20, 2002 |
|
|
|
/s/ John P. Funkhouser
|
| |
|
|
|
John P. Funkhouser President and Chief Executive Officer |